Form 4: Health Catalyst CEO Sells Shares for Tax Obligations

Health Catalyst CEO Benjamin Albert disposed of 70,455 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Benjamin Albert, CEO and Director of Health Catalyst, Inc. (HCAT), disposed of 70,455 shares of common stock on March 10, 2026.
• The shares were sold at a price of $1.8481 per share.
• This transaction was a 'sell to cover' to satisfy tax withholding obligations in connection with the vesting of the Issuer's Restricted Stock Units.
• The sale was mandated by Health Catalyst's equity incentive plans and was not a discretionary trade by Mr. Albert.
• Following this transaction, Benjamin Albert beneficially owns 1,457,978 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a non-discretionary 'sell to cover' for tax purposes, which is a routine administrative action for executives receiving equity compensation.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common and routine mechanism for executives to satisfy tax obligations upon the vesting of equity awards, and are generally not interpreted as a signal of management's sentiment regarding the company's future prospects, unlike discretionary sales.

Key Dates

Recommendation

The transaction is a routine 'sell to cover' for tax withholding obligations related to RSU vesting and is explicitly stated as not being a discretionary trade. This type of insider transaction typically has minimal impact on the investment thesis and does not signal a change in management's confidence in the company. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new fundamental information to warrant a change in investment strategy.

Keywords

Health Catalyst, HCAT, Form 4, Insider Transaction, CEO, Benjamin Albert, Restricted Stock Units, RSU, Tax Withholding, Sell to Cover